SLN biopsy for large and/or multicentric breast cancers: Should we worry?

European Journal of Surgical Oncology

Volumn 37, Issue 5, 2011, Pages 386-387

  Cody III, Hiram S ^a,b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXILLARY LYMPH NODE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DIAGNOSTIC TEST ACCURACY STUDY; FALSE NEGATIVE RESULT; HEALTH CARE POLICY; HUMAN; MASTECTOMY; MEDICAL LITERATURE; NOTE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENTINEL LYMPH NODE BIOPSY; STANDARD;

EID: 79954420376     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2011.02.006     Document Type: Letter

References (11)

1. T. Kim, A.E. Giuliano, and G.H. Lyman Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma Cancer 106 2006 4 16 (Pubitemid 43033320)
2. U. Veronesi, G. Paganelli, and G. Viale A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer N Engl J Med 349 2003 546 553 (Pubitemid 36951366)
3. D.N. Krag, S.J. Anderson, and T.B. Julian Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial Lancet Oncol 8 2007 881 888 (Pubitemid 47488052)
4. R.E. Mansel, L. Fallowfield, and M. Kissin Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial J Natl Cancer Inst 98 2006 599 609 (Pubitemid 43904843)
5. G. Zavagno, G.L. De Salvo, and G. Scalco A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial Ann Surg 247 2008 207 213 (Pubitemid 351156760)
6. G. Gill Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial Ann Surg Oncol 16 2009 266 275
7. E.J. Rutgers Sentinel node biopsy: interpretation and management of patients with immunohistochemistry-positive sentinel nodes and those with micrometastases J Clin Oncol 26 2008 698 702 (Pubitemid 351264381)
8. Early Breast Cancer Trialists' Collaborative Group Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2005 2087 2106
9. A.E. Giuliano, L. McCall, and P. Beitsch Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial Ann Surg 252 2010 426 433
10. A.E. Giuliano, L.M. McCall, and P.D. Beitsch ACOSOG Z0011: a randomized trial of axillary node dissection in women with clinical T1-2 N0 M0 breast cancer who have a positive sentinel node J Clin Oncol (Meeting Abstracts) 28 2010 CRA506
11. E.R. Port, S. Patil, and M. Stempel Number of lymph nodes removed in sentinel lymph node-negative breast cancer patients is significantly related to patient age and tumor size: a new source of bias in morbidity assessment? Cancer 2010